Impact of Sacubitril/Valsartan on the Long-Term Incidence of Ventricular Arrhythmias in Chronic Heart Failure Patients.
Ibrahim El-BattrawyChristina PilsingerVolker LiebeSiegfried LangJürgen KuschykXiao-Bo ZhouMartin BorggrefeSusanne RögerIbrahim AkinPublished in: Journal of clinical medicine (2019)
Sacubitril/valsartan does not reduce the risk of ventricular tachyarrhythmias in chronic HFrEF patients over 12 months of follow-up.